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Accepted 22 August 2016Most studies of infectious diseases in East African cattle have concentrated on gastro-intestinal parasites and vec-
tor-borne diseases. As a result, relatively little is known about viral diseases, except for those that are clinically
symptomatic or which affect international trade such as foot and mouth disease, bluetongue and epizootic
haemorrhagic disease. Here,we investigate the seroprevalence, distribution and relationship between the viruses
involved in respiratory disease, infectious bovine rhinotracheitis virus (IBR), bovine parainﬂuenza virus Type 3
(PIV3) and bovine viral diarrhoea virus (BVDV) in East African Shorthorn Zebu calves. These viruses contribute
to the bovine respiratory disease complex (BRD) which is responsible for major economic losses in cattle from
intensive farming systems as a result of pneumonia. We found that calves experience similar risks of infection
for IBR, PIV3, and BVDV with a seroprevalence of 20.9%, 20.1% and 19.8% respectively. We conﬁrm that positive
associations exist between IBR, PIV3 and BVDV; being seropositive for any one of these three viruses means
that an individual is more likely to be seropositive for the other two viruses than expected by chance.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).Keywords:
Cattle
Bovine respiratory disease complex
Infectious bovine rhinotracheitis
Bovine parainﬂuenza virus type 3
Bovine viral diarrhoea virus
Zebu1. Introduction
Most studies of infectious diseases in East African cattle have con-
centrated on gastro-intestinal parasites and vector-borne diseases. As
a result, relatively little is known about viral diseases, except for those
that are clinically symptomatic or which affect international trade
such as foot andmouth disease, bluetongue and epizootic haemorrhagic
disease (Bronsvoort et al., 2003; Toye et al., 2013). Yet, in the rest of the
world, other viral diseases are known to have a large impact upon the
livestock industry. For example, bovine respiratory disease complex
(BRD) is responsible for major economic losses in cattle from intensive
farming systems as a result of pneumonia (Bowland and Shewen, 2000).
Furthermore, studies of intensively farmed feedlot and beef cattle in
North America have shown that individuals infected with BRD exhibitment Centre, Animal and Plant
llaby).
. This is an open access article undera decreased growth rate and some individuals show signs of clinical ill-
ness (Gardner et al., 1999; Schneider et al., 2009; White and Renter,
2009).
There are many factors which contribute to the BRD, including
stress, management practices and biological agents (Snowder et al.,
2006; Taylor et al., 2010). Viruses have been implicated in contributing
to BRD by causing lesions in the bovine respiratory tract and/or
impairing the clearance of bacteria from the lower respiratory tract
(Coetzer and Tustin, 2004). Some of the viruses contributing to BRD in-
clude infectious bovine rhinotracheitis virus (IBR), bovine parainﬂuenza
virus type 3 (PIV3) and bovine viral diarrhoea virus (BVDV). Each of
these viruses has speciﬁc clinical signs, consequences and economic im-
portance (see Appendix). In addition, both IBR and BVDV are immuno-
suppressive (Hutchings et al., 1990; Koppers-Lalic et al., 2001; Roth et
al., 1986; Wellenberg et al., 2002). Numerous epidemiological studies
have reported positive associations between these viruses (Fulton et
al., 2000; Martin and Bohac, 1986) and the relationship has been
reviewed since the 1980s (Yates, 1982). Although these viruses have
been documented in many parts of the world (Coetzer and Tustin,the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1
Crude and adjusted seroprevalence of each virus. Seroprevalence is followed by the 95% conﬁdence interval in brackets. IBR = infectious bovine rhinotracheitis; PIV3 = bovine
parainﬂuenza virus type 3; BVDV= bovine viral diarrhoea virus.
Virus Number of seropositive calves Number of calves tested Crude Seroprevalence
(95% CI)
Adjusted Seroprevalence
(95% CI)
IBR 91a 455 20.00 (16.42–23.98) 20.90 (16.41–25.39)
PIV3 80 455 17.62 (14.23–21.44) 20.08 (15.52–24.63)
BVDV (antibody test) 79 454 17.36 (13.99–21.16) 19.76 (15.17–24.36)
a 66 of the IBR inconclusive calves (according to the manufacturers cut-offs) were classiﬁed as seropositive following the case-case analysis in the appendix.
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Africa, particularly in East African extensive farming systems.
The purpose of this study is to improve current knowledge on the se-
roprevalence and distribution of IBR, PIV3, and BVDV in cattle in sub-Sa-
haran Africa by estimating the seroprevalence to these viruses in East
African shorthorn zebu calves fromWestern Kenya using data gathered
by the Infectious Diseases of East Africa Livestock (IDEAL) project. We
aim to quantify the associations between these viruses within this
study population.a) b)
Fig. 1.Map ofwestern Kenya showing the distribution of calves seropositive for a) IBR; b) PIV3 a
coloured different shades of green and the 20 sublocations in the study area are shaded accord
location of the project laboratory in Busia. The small insert map shows the study area, in grey,2. Material and Methods
2.1. Study Population
The study reported here uses data gathered as part of the Infec-
tious Diseases of East Africa Livestock (IDEAL) project, the design of
which has previously been reported by Bronsvoort et al. (2013).
Brieﬂy, the IDEAL project was an intensive cohort study of 548 indig-
enous shorthorn zebu calves from 3 to 7 days old which werec)
nd c) BVDV antibody at 51weeks of age. Themap also shows theﬁve agro-ecological zones
ing the observed seroprevalence for each virus within them. The blue circle indicates the
in relation to the whole of Kenya.
Fig. 2. Correlation matrix showing the correlation between seroconversion to IBR, PIV3
and BVDV antibody without correcting for any other variables.
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September 2010.
Calves were selected using a stratiﬁed two-stage random cluster
study design. In the ﬁrst stage, 20 sublocations (the smallest admin-
istrative unit in Kenya) were selected from 5 agro-ecological zones,
in a radius of 45 km from the town of Busia for logistical reasons.
This area is dominated by smallholder mixed crop-livestock produc-
tion systems, with an average farm size of 2 ha and about 5 cattle per
farm (Bronsvoort et al., 2013). During the second sampling stage, 28
calves from each sublocation were recruited. To be recruited into the
study, calves were aged between 3 and 7 days old, their dam had to
have been on the farm for at least one year, the calf was not a result
of artiﬁcial insemination and the herd should have been under open
grazing management. Only one dam and calf from a farm could be in
the study at any time. This study focuses on the 455 calves which sur-
vived until 51 weeks old.
2.2. Data Collection
At the recruitment visit, the calf's owner completed a questionnaire.
This questionnaire collected environmental information about the
farm, other livestock, water sources and animal husbandry practices.
Calf locations were geo-referenced using hand-held GPS devices
(Garmin 12, Garmin Kansas, USA). During the study calves were
weighed (measured to the nearest 0.5 kg) and the dam's girth was
measured (measured in cm) and the calves had biological samples
taken for laboratory analysis.
2.3. Laboratory Analysis
2.3.1. Viruses
Jugular vein blood samples were collected in plain Vacutainer™
(Becton Dickinson, England) tubes. Blood samples were allowed to
clot, the serum was recovered and aliquots were stored at −20 °C,
until serological analysis could take place.
Serological samples taken from calves at 51 weeks of age were
screened using SVANOVIR kits obtained from Svanova Biotech AB
(Uppsala, Sweden) to identify antibodies speciﬁc to the following
viruses: a) infectious bovine rhinotracheitis (IBR); b) bovine viral
diarrhoea virus (BVDV) antibody and c) bovine parainﬂuenza
virus type 3 (PIV3). In addition, the sera were screened for the
presence of BVDV antigens using kits obtained from IDEXX (Mont-
pellier SAS, France). All the kits (apart from the BVDV antigen kit)
were designed to detect virus speciﬁc IgG antibodies in serum
using a procedure based upon a solid phase indirect Enzyme Linked
Immunosorbent Assay (Indirect ELISA). All assays were performed
and analysed according to the manufacturer's instructions using
single wells. There is no evidence for cross-reactivity between the
tests.
The SVANOVIR ELISA tests are based on the measurement of
corrected optical density (ODcorr). To calculate the ODcorr, values in
wells coated with a particular antigen are corrected by subtracting
the OD values of corresponding wells containing the control antigenTable 2
Odds ratio and 95% conﬁdence interval from the virus-only analyses of the association betwee
Response virus Explanatory virus
IBR PIV3
OR 95% CI P value OR 95% CI
IBR – – – 2.77 1.53–5.03
PIV3 2.76 1.53–4.98 0.001 – –
BVDV (antibody test) 2.77 1.56–4.92 0.001 5.98 3.40–10.5(ODtest antigen − ODcontrol = ODcorr). The Percent Positivity (PP)
values are calculated as follows:
Percent Positivity ¼ Test Sample ODcorrð Þ  100
Positive Control ODcorrð Þ
IDEXX ELISA test results are interpreted using a similar index called
the “sample to positive control percentage” (S/P%), which was calculat-
ed according to the manufacturer's instructions for the test.
To convert the continuous PP (or S/P%) values into a serostatus
which is a binary seropositive/seronegative outcome, the PP (or S/P%)
values were interpreted according to the manufacturer's cut-offs speci-
ﬁed in the appendix. Justiﬁcation for grouping the inconclusive IBR re-
sults with the IBR seropositive individuals is presented in the
appendix. Therefore, seropositive/seronegative means antibodies to
the antigen of interest are detectable/not detectable in the blood of
the host, whereas seroconversion is the movement from a seronegative
to a seropositive state.
2.4. Statistical Analysis
2.4.1. Seroprevalence of the Viruses
The crude seroprevalence for each virus was calculated using the
epicalc package in R v.2.15.2 (Chongsuvivatwong, 2012). The weighted
adjusted seroprevalence for each viruswas calculated using the R survey
package (Lumley, 2012). The weighting adjusted for the number of
breeding dams in each sublocation. Sublocation-speciﬁc seroprevalence
was mapped using ArcGIS.n seroconversion to IBR, PIV3 and BVDV.
Random effect:
Sublocation
BVDV
P value OR 95% CI P value Variance SD
0.001 2.77 1.54–5.00 0.001 0.15 0.38
– 5.87 3.30–10.46 b0.001 0.14 0.38
2 b0.001 – – – 0.00 0.00
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The association between the three viruseswas assessed using gener-
alised linearmixedmodels (GLMM) ﬁtted with a logit link function and
binomial errors and a Laplace approximation to the maximum likeli-
hood estimation in R v.2.15.2 using the lme4 package (Bates et al.,
2014). We investigate the association between the serostatus of virus
A at 51 weeks old with serostatus of the other viruses at 51 weeks
with the following model structure:
logit Virus A serostatusið Þ
¼ α þ β1 Virus B serostatusi þ β2 Virus C serostatusi þ Sublocationi
whereα is the intercept.Virus X serostatusi is the serostatus of the calf (i)
at 51weeks of age for each virus, and is included in themodels as a ﬁxed
effect (β). Sublocation (Sublocation, 20 levels) is included in the model
as a random effect (b) to account for the study design and environmen-
tal similarity between calves clustered into each sublocation.
A separate model was constructed for each virus. Viruses were said
to be co-distributed if they occurred in an individual more often than
expected by chance. The same patterns of association were examined
using continuous measures of PP values instead of serostatus (see the
Appendix). Interaction between the viruses was also considered, how-
ever including an interaction term between the viruses did not improve
the ﬁt of any of the models.
Following construction of the virus-only model, environmental con-
founders associated with the virus with a p b 0.2 in the univariate anal-
ysis (listed in the Appendix), whichmay affect respiratory pathogens or
contact between calves, were added into each of themodels. Backwards
stepwise selection was then used to remove variables to produce the
most parsimonious model.
By using a two stage statistical approach it was possible to examine
whether the associations between being seropositive for the different
viruses was due to coinfection or if the associations were being driven
by a joint underlying correlation such as a shared environmental factor
or calf characteristic.
3. Results
3.1. Seroprevalence of the Viruses
The seroprevalence at 51 weeks was similar for each virus; IBR had
an adjusted seroprevalence of 20.9% whilst PIV3 and BVDV antibodies
had adjusted seroprevalences of 20.1% and 19.8%, respectively (Table
1). We observed that 111 (24.4%), 35 (7.7%) and 23 (5.1%) calves were
seropositive for 1, 2 or 3 viruses, respectively. Two hundred and eighty
ﬁve (62.6%) calves were seronegative for all three virus antibodies.
BVDV antigen was not detected in the serum of any animal. The sero-
prevalence of the viruses in each sublocation is plotted in Fig. 1.
3.2. Associations between Viruses
The virus-only GLMMs indicated that IBR, PIV3 and BVDV were co-
distributed (Table 2). There was an increased risk of an individual
being seropositive for one of these viruses, if the calf was also seroposi-
tive for one or both of the other viruses (Table 2). In addition, a positive
correlation was observed between the three viruses (Fig. 2). The same
pattern of resultswere observed using PP value as a continuous variable
(results not shown).
Inclusion of environmental confounders in the virus-only models
did not affect the relationship observed between the serostatus of the
three viruses; the most parsimonious model for all three viruses was
the one which excluded all environmental variation (Table 2). Even in
the univariate analysis, all of 17 environmental risk factors considered
had a p value N0.01 and did not alter the direction or magnitude of
the associations with any of the three viruses (see Appendix).4. Discussion
This study aimed to describe the prevalence and association of vi-
ruses involved in the bovine respiratory disease complex (BRD) in
Western Kenya. We have shown that IBR, PIV3 and BVDV all have
an estimated seroprevalence of around 20%. The observed seroprev-
alence of IBR is within the range (16%–54%) that McDermott et al.
(1997) estimated for three districts in Kenya (not including the
Busia district) in 1991–1992. However the seroprevalence of the
three viruses is lower than that observed in traditionally managed
herds in Zambia, which range from 42%–76% (Ghirotti et al., 1991)
and lower than the prevalence's observed smallholder farms in
coastal Kenya (BVDV prevalence = 45.8%; IBR prevalence = 28.6%;
Kenyanjui et al. (2007)). All three viruses are transmitted via secre-
tions or aerosols, in addition, vertical transmission of BVDV can
also occur. Therefore one explanation for the difference observed is
that the herd sizes in the Zambian study range from 20 to 100 cattle
(Ghirotti et al., 1991). IBR, PIV3 and BVDV are observed at higher
prevalences in larger herd sizes and they are more common in inten-
sively farmed animals, where there is a high level of contact between
individuals (Snowder et al., 2006). Cattle in the IDEAL project are ex-
tensively farmed, with a median herd size of 5 and so the risk of con-
tact between a susceptible individual with an infected or persistently
infected individual is lower. Furthermore, the cattle in Ghirotti et al.
(1991) included individuals aged 3 months to adults, whereas the
IDEAL calves were aged 51 weeks old, so there may also be differ-
ences in age-related seroprevalence. Moreover, both Ghirotti et al.
(1991) and Kenyanjui et al. (2007) used the virus neutralization
tests instead of ELISA tests, therefore differences in test sensitivity
and speciﬁcity may also be contributing to the differences observed
in prevalence (Graham et al., 1998). In addition, no BVDV antigen
positive calves were identiﬁed in this study, suggesting that there
are no persistently infected individuals (Brock, 2003).
Cross-reactivity may occur between a virus and its related viruses.
For example, BVDV is cross-reactive with other pestiviruses such as
Classical Swine Fever and Border Disease Virus of sheep; IBR is cross-re-
active with four herpesviruses from other animals including goats and
buffalo; and PIV3 cross-reacts with human strains of the virus
(Coelingh et al., 1986; Handel et al., 2011; Lyaku et al., 1992). However,
since none of the above viruses are expected to be found in cattle in
western Kenya, themajority of seropositivitywas likely due to exposure
to the virus of interest.
In accordancewith numerous other epidemiological studies, but in a
previously unstudied setting, this analysis has found that IBR, PIV3 and
BVDV are associated (Durham and Hassard, 1990; Fulton et al., 2000;
Martin and Bohac, 1986). Inclusion of environmental confounders into
the models quantifying the relationship between the serostatus of the
three viruses had little effect on the association observed between
them. Other studies have suggested that at the herd level the main
risk factors for BRD are the production type, herd size, housing andman-
agement practices such as animal movement and hygiene (Gay and
Barnouin, 2009). Risk factors for IBR include increased movement into
the herd and distance to neighbouring farms, which increases the risk
of infection through contacts with infected individuals (van Schaik et
al., 1998). Risk factors for PIV3 and BVDV includes age (Figueroa-
Chavez et al., 2012). In addition, the presence of a persistently infected
individual can increase BVDV risk (Mainar-Jaime et al., 2001). Since all
the calves in this study were the same age when testing took place
and sublocation was ﬁtted as a random effect, this variation was re-
moved from the study.
To conclude, this study shows that the viruses IBR, PIV3 and BVDV
are co-circulating in East African shorthorn zebu calves in Western
Kenya. We identiﬁed positive associations occurring between IBR,
PIV3 and BVDV in a previously unstudied setting. Further studies are
needed to identify the long-term impact of these viruses on cattle pro-
ductivity and their interactions with other parasites.
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